Skip to main content

Table 1 Baseline characteristics of patients in two groups divided by GNRI

From: Relationship between mortality and Geriatric Nutritional Risk Index (GNRI) at the time of dialysis initiation: a prospective multicenter cohort study

Parameter High group (n = 728) Low group (n = 761) P value
Male (%) 69.4 66.0 0.1607
Age (years) 65.8 ± 13.2 69.1 ± 12.8 <0.001
Height (cm) 160.1 ± 9.2 158.8 ± 9.7 0.0059
Body weight (kg) 62.0 ± 13.1 58.2 ± 14.1 <0.001
BMI (kg/cm2) 24.0 ± 4.0 22.9 ± 4.5 <0.001
GNRI 95.2 ± 4.9 80.3 ± 6.1 <0.001
UFV (L) 0.801 ± 0.827 0.967 ± 0.919 <0.001
ACEi or ARB (%) 64.0 57.4 0.0093
β blocker (%) 36.7 33.2 0.1652
Statin (%) 39.7 40.5 0.7603
VDRA (%) 32.6 22.9 <0.001
ESA (%) 88.9 84.1 0.0072
Diabetes (%) 44.5 57.6 <0.001
History of CAD (%) 14.7 18.8 0.0347
History of PCI (%) 9.5 10.9 0.3627
History of CABG (%) 3.7 4.6 0.3899
History of HF Ad (%) 16.6 24.3 0.0002
History of CI (%) 12.6 14.6 0.2733
History of ICH (%) 3.2 2.6 0.5406
History of AD (%) 5.1 6.0 0.4185
History of PAD, F2 (%) 3.6 5.7 0.0564
Amputation (%) 1.0 2.1 0.0743
CVD (%) 40.1 49.5 0.0003
Comorbid MI (%) 4.0 7.2 0.0067
Comorbid HF (%) 18.3 31.5 <0.001
Comorbid PAD (%) 3.7 6.4 0.0167
Comorbid stroke (%) 7.4 10.1 0.0659
SBP (mmHg) 152.5 ± 25.4 150.1 ± 26.4 0.0694
CTR (%) 54.1 ± 7.2 56.2 ± 6.9 <0.001
WBC (1000/μL) 6.3 ± 2.9 7.1 ± 3.3 <0.001
Hb (g/dL) 9.77 ± 1.45 9.00 ± 1.54 <0.001
Plt (10000/μL) 17.3 ± 7.2 19.0 ± 7.9 <0.001
ALB (g/dL) 3.67 ± 0.34 2.75 ± 0.41 <0.001
eGFR (ml/min/1.7m2) 5.21 ± 1.84 5.67 ± 2.52 <0.001
Na (mEq/L) 138.2 ± 4.0 137.6 ± 4.7 0.0045
K (mEq/L) 4.61 ± 0.77 4.48 ± 0.838 0.0020
cCa (mg/dL) 8.44 ± 1.05 8.78 ± 1.03 <0.001
P (mg/dL) 6.23 ± 1.61 6.48 ± 2.10 0.0095
Mg (mg/dL) 2.20 ± 0.50 2.10 ± 0.44 <0.001
UA (mg/dL) 8.71 ± 2.33 8.82 ± 2.45 0.3660
LDL-C (mg/dL) 87.5 ± 31.9 92.0 ± 36.6 0.0168
CRP (mg/dL) 0.88 ± 2.48 2.68 ± 5.10 <0.001
TSAT (%) 28.4 ± 16.3 25.9 ± 16.9 0.0130
Ferritin (ng/mL) 221.6 ± 1328.5 220.5 ± 506.0 0.9846
LVEF (%) 60.8 ± 12.5 60.6 ± 12.0 0.7771
All-cause death (%) 12.6 22.2 <0.001
Infection death (%) 1.9 5.5 0.0003
CVD death (%) 5.2 7.6 0.0593
Malignancy death (%) 3.0 3.0 0.9998
  1. GNRI Geriatric Nutritional Risk Index, UFV ultrafiltlation volume, BMI body mass index, ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, VDRA vitamin D receptor agonist, ESA erythropoietin stimulating agent, CAD coronary artery disease, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, HF heart failure, Ad admission, CI cerebral infarction, ICH intracerebral hemorrhage, AD aortic disease, PAD, F2 peripheral arterial disease with Fontaine classification 2-4, CVD cardiovascular disease, MI myocardial infarction, SBP systolic blood pressure, CTR cardiothoracic ratio, WBC white blood cells, Hb hemoglobin, Plt platelet, ALB albumin, eGFR estimated glomerular filtration rate, Na sodium, K potassium, cCa corrected calcium, P phosphate, Mg magnesium, UA uric acid, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, TSAT transferrin saturation, LVEF left ventricular ejection fraction, CVD cardiovascular disease